Implementing sensor-based digital health technologies in clinical trials: Key considerations from the eCOA Consortium.

导出 OA

翻译打印收藏纠错

作者： Elena S,Izmailova ^[1] ; Danielle,Middleton ^[2] ; Reem,Yunis ^[3] ; Julia,Lakeland ^[4] ; Kristen,Sowalsky ^[5] ; Julia,Kling ^[1] ; Alison,Ritchie ^[6] ; Christine C,Guo ^[7] ; Bill,Byrom ^[8] ; Scottie,Kern ^[9]

作者单位： Koneksa Health, New York, New York, USA. ^[1] AstraZeneca PLC, Cambridge, UK. ^[2] Medable, Inc, Palo Alto, California, USA. ^[3] uMotif Ltd, London, UK. ^[4] APDM Wearable Technologies, a Clario Company, Portland, Oregon, USA. ^[5] Parexel International, Sheffield, UK. ^[6] ActiGraph LLC, Pensacola, Florida, USA. ^[7] Signant Health, London, UK. ^[8] Critical Path Institute, Tucson, Arizona, USA. ^[9]

主题词人类(Humans);临床试验(主题)(Clinical Trials as Topic);生物医学技术(Biomedical Technology);病人依从(Patient Compliance);研究设计(Research Design)

DOI 10.1111/cts.70054

PMID 39491883

发布时间 2024-11-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交